Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis
Frontiers in Pharmacology · 09.07.2024 · 15
DOI: 10.3389/fphar.2024.1416705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.07.2024. Verfasst von Piyasuda Pukkanasut und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL, United States. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
This review focuses on the expression and function of voltage-gated sodium channel subtype Na V 1.7 in various cancers and explores its impact on the metastasis driving cell functions such as proliferation, migration, and invasiveness. An overview of its structural characteristics, drug binding sites, inhibitors and their likely mechanisms of action are presented. Despite the lack of clarity on the precise mechanism by which Na V 1.7 contributes to cancer progression and metastasis; many studies have suggested a connection between Na V 1.7 and proteins involved in multiple signaling pathways such as PKA and EGF/EGFR-ERK1/2. Moreover, the functional activity of Na V 1.7 appears to elevate the expression levels of MACC1 and NHE-1, which are controlled by p38 MAPK activity, HGF/c-MET signaling and c-Jun activity. This cascade potentially enhances the secretion of extracellular matrix proteases, such as MMPs which play critical roles in cell migration and invasion activities. Furthermore, the Na V 1.7 activity may indirectly upregulate Rho GTPases Rac activity, which is critical for cytoskeleton reorganization, cell adhesion, and actin polymerization. The relationship between Na V 1.7 and cancer progression has prompted researchers to investigate the therapeutic potential of targeting Na V 1.7 using inhibitors. The positive outcome of such studies resulted in the discovery of several inhibitors with the ability to reduce cancer cell migration, invasion, and tumor growth underscoring the significance of Na V 1.7 as a promising pharmacological target for attenuating cancer cell proliferation and metastasis. The research findings summarized in this review suggest that the regulation of Na V 1.7 expression and function by small molecules and/or by genetic engineering is a viable approach to discover novel therapeutics for the prevention and treatment of metastasis of cancers with elevated Na V 1.7 expression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL, United States.
- Department of Surgery, The University of Alabama at Birmingham, Birmingham, AL, United States.
- O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, United States.
- Departamento de Neuropatología Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
Zitieren
APA
Pukkanasut, P., Jaskula-Sztul, R., Gomora, J. C., & Velu, S. E. (2024). Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1416705
Vancouver
Pukkanasut P, Jaskula-Sztul R, Gomora JC, Velu SE. Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1416705
BibTeX
@article{Pukkanasut2024,
author = {Pukkanasut, Piyasuda and Jaskula-Sztul, Renata and Gomora, Juan Carlos and Velu, Sadanandan E},
title = {Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1416705}
}
EUVIMED